BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2844351)

  • 1. Urinary catecholamine metabolite and tribulin output during lactate infusion.
    Clow A; Glover V; Weg MW; Walker PL; Sheehan DV; Carr DB; Sandler M
    Br J Psychiatry; 1988 Jan; 152():122-6. PubMed ID: 2844351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
    Petursson H; Bond PA; Smith B; Lader MH
    Biol Psychiatry; 1983 Feb; 18(2):207-13. PubMed ID: 6187380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tribulin: an endogenous monoamine oxidase inhibitor/benzodiazepine receptor ligand.
    Sandler M; Glover V; Clow A; Elsworth JD
    Prog Clin Biol Res; 1985; 192():359-62. PubMed ID: 3001762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion.
    Schmidt RT; Stahl SM; Spehlmann R
    Neurology; 1975 Jul; 25(7):622-6. PubMed ID: 1171392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of 4-O-methylated catecholamine metabolites in urine by mass fragmentography.
    Muskiet FA; Fremouw-Ottevangers DC; Nagel GT; Wolthers BG
    Clin Chem; 1979 Oct; 25(10):1708-13. PubMed ID: 476919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of theophylline on neurotransmitters in preterm infants with apnea.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Clin Neuropharmacol; 1983 Mar; 6(1):71-4. PubMed ID: 6133614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and response to sodium lactate of patients with infrequent panic attacks.
    Cowley DS; Dager SR; Foster SI; Dunner DL
    Am J Psychiatry; 1987 Jun; 144(6):795-8. PubMed ID: 3592002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of peripheral catecholamines and indole amines in healthy persons. Clinico-biochemical correlates].
    Krzyzowski J; Lewicka-Wysocka H; Lukaszewska B; Marcjan K; Pacyna M; Pietruszewska I; Roguska E; Stencka K
    Pol Tyg Lek; 1981 Mar; 36(11):417-21. PubMed ID: 6167972
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of naloxone on patients with panic attacks.
    Liebowitz MR; Gorman JM; Fyer AJ; Dillon DJ; Klein DF
    Am J Psychiatry; 1984 Aug; 141(8):995-7. PubMed ID: 6087689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate infusion in anxiety research: its evolution and practice.
    Sheehan DV; Carr DB; Fishman SM; Walsh MM; Peltier-Saxe D
    J Clin Psychiatry; 1985 May; 46(5):158-65. PubMed ID: 3988715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
    Popa M; Stefănescu AM; Dumitriu L
    Endocrinologie; 1986; 24(3):203-14. PubMed ID: 3775226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and precursor availability affect urinary catecholamine metabolite production in women.
    Johnston JL; Warsh JJ; Anderson GH
    Am J Clin Nutr; 1983 Sep; 38(3):356-68. PubMed ID: 6613910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
    Modai I; Beigel Y; Cygielman G
    J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
    Garvey M; Noyes R; Cook B; Tollefson G
    Psychiatry Res; 1989 Oct; 30(1):53-61. PubMed ID: 2594871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the drug treatment of anxiety disorders.
    Pohl R; Rainey JM; Gershon S
    Psychopathology; 1984; 17 Suppl 1():6-14. PubMed ID: 6369369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple high-performance liquid chromatographic method for the concurrent determination of the amine metabolites vanillylmandelic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, dihydroxyphenylacetic acid and homovanillic acid in urine using electrochemical detection.
    Joseph MH; Kadam BV; Risby D
    J Chromatogr; 1981 Dec; 226(2):361-8. PubMed ID: 6172439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of neurotransmitters in premature infants with or without apnea of prematurity.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Clin Neuropharmacol; 1982 Dec; 5(4):389-94. PubMed ID: 6130840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium lactate infusion, panic attacks, and ionized calcium.
    Fyer AJ; Gorman JM; Liebowitz MR; Levitt M; Danielson E; Martinez J; Klein DF
    Biol Psychiatry; 1984 Oct; 19(10):1437-47. PubMed ID: 6518201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of laboratory-induced panic-anxiety on subsequent provocative infusions.
    Yeragani VK; Balon R; Rainey JM; Ortiz A; Berchou R; Lycaki H; Pohl R
    Psychiatry Res; 1988 Feb; 23(2):161-6. PubMed ID: 3363025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.